RIMONDI, Erika
 Distribuzione geografica
Continente #
NA - Nord America 3.392
EU - Europa 1.518
AS - Asia 1.199
SA - Sud America 135
Continente sconosciuto - Info sul continente non disponibili 94
AF - Africa 48
OC - Oceania 2
Totale 6.388
Nazione #
US - Stati Uniti d'America 3.342
PL - Polonia 513
SG - Singapore 425
CN - Cina 309
SE - Svezia 216
UA - Ucraina 160
IT - Italia 148
HK - Hong Kong 124
VN - Vietnam 114
BR - Brasile 106
FR - Francia 83
GB - Regno Unito 81
FI - Finlandia 73
KR - Corea 61
DE - Germania 52
TR - Turchia 52
RU - Federazione Russa 51
BG - Bulgaria 34
IE - Irlanda 33
IN - India 32
CA - Canada 27
MA - Marocco 26
BD - Bangladesh 21
CH - Svizzera 21
NL - Olanda 17
BE - Belgio 13
IQ - Iraq 11
MX - Messico 10
MY - Malesia 10
AR - Argentina 9
JP - Giappone 9
CL - Cile 5
LT - Lituania 5
ZA - Sudafrica 5
CO - Colombia 4
ES - Italia 4
ID - Indonesia 4
DZ - Algeria 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
SN - Senegal 3
VE - Venezuela 3
AL - Albania 2
AM - Armenia 2
AT - Austria 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
IR - Iran 2
LV - Lettonia 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
TN - Tunisia 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.296
Città #
Warsaw 479
Woodbridge 361
Ashburn 327
Fairfield 321
Ann Arbor 305
Singapore 269
Houston 234
Chandler 225
Wilmington 156
Jacksonville 152
San Jose 129
Hong Kong 124
Seattle 115
Cambridge 93
Beijing 73
Dallas 68
Boardman 62
Hefei 62
Seoul 61
Princeton 58
Izmir 46
Council Bluffs 42
Chicago 38
Ho Chi Minh City 38
Lauterbourg 36
Sofia 34
Columbus 33
Dearborn 32
Dublin 32
Trieste 32
Los Angeles 30
Buffalo 29
Zgierz 29
Hanoi 27
London 26
Casablanca 23
Helsinki 21
Moscow 21
Santa Clara 21
Frankfurt am Main 18
San Diego 18
Bern 16
New York 16
São Paulo 16
Milan 14
The Dalles 14
Brussels 13
Düsseldorf 12
Tokyo 9
Dong Ket 8
Falls Church 8
Nanjing 8
Orem 8
Atlanta 7
Chennai 7
Guangzhou 7
Ottawa 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Toronto 6
Auburn Hills 5
Denver 5
Des Moines 5
Ferrara 5
Haiphong 5
Jinan 5
Johannesburg 5
Kunming 5
Mumbai 5
Phoenix 5
Redondo Beach 5
Kuala Lumpur 4
Miano 4
Nanchang 4
Nuremberg 4
Shanghai 4
Wroclaw 4
Zurich 4
Amsterdam 3
Baghdad 3
Belo Horizonte 3
Bogotá 3
Boston 3
Brooklyn 3
Chengdu 3
Dakar 3
Dhaka 3
Fortaleza 3
Fremont 3
Hangzhou 3
Hưng Yên 3
Manchester 3
Montreal 3
Nairobi 3
North Bergen 3
Norwalk 3
Portsmouth 3
San Francisco 3
Santiago 3
Totale 4.639
Nome #
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 396
The anti-leukemic activity of sodium dichloroacetate in p53mutated/null cells is mediated by a p53-independent ILF3/p21 pathway 364
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 318
C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway. 270
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 250
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors. 233
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 232
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 230
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 225
MDM2 antagonist nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts via a p53-dependent pathway. 223
Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells. 217
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 212
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 209
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. 207
TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points:induction of apoptosis and PGE2 release. 200
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 199
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 196
Receptor activator of nuclear factor kappa B ligand(RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts. 195
GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 195
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 189
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1. 185
Human colostrum and breast milk contain high levels of TNF-related apoptosis-inducing ligand (TRAIL). 183
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 182
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 168
Levels of TNF-related apoptosis-inducing ligand (TRAIL) show a long-term stability in the breast milk of mothers of preterm infants. 157
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 154
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 143
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 136
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 118
Role of vitamin D in the pathogenesis of atheromatosis 111
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation 91
Totale 6.388
Categoria #
all - tutte 17.647
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.647


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022354 0 19 20 50 8 30 23 11 46 32 23 92
2022/2023578 39 83 54 96 48 107 2 49 70 5 21 4
2023/2024256 26 28 10 18 30 17 43 46 1 2 13 22
2024/2025605 13 32 53 65 46 61 58 26 63 74 68 46
2025/20261.673 166 83 153 164 171 141 197 56 207 221 60 54
2026/202762 50 12 0 0 0 0 0 0 0 0 0 0
Totale 6.388